Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,453 | -4,442 | -1,968 | -3,877 | -1,350 |
| Depreciation Amortization | 8 | 5 | 2 | 20 | 19 |
| Accounts payable and accrued liabilities | -39 | -139 | -98 | 154 | 160 |
| Other Working Capital | -357 | -726 | -131 | -426 | -241 |
| Other Operating Activity | 970 | 704 | 341 | 576 | 335 |
| Operating Cash Flow | $-5,871 | $-4,598 | $-1,855 | $-3,554 | $-1,078 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -18 | -6 | -20 | -8 |
| Investing Cash Flow | $-18 | $-18 | $-6 | $-20 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 10,295 | 1,507 |
| Other Financing Activity | -45 | 0 | 0 | -35 | -77 |
| Financing Cash Flow | $-45 | $N/A | $N/A | $10,260 | $1,431 |
| Beginning Cash Position | 7,241 | 7,241 | 7,241 | 555 | 555 |
| End Cash Position | 1,307 | 2,626 | 5,380 | 7,241 | 900 |
| Net Cash Flow | $-5,934 | $-4,616 | $-1,862 | $6,686 | $344 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,871 | -4,598 | -1,855 | -3,554 | -1,078 |
| Capital Expenditure | -18 | -18 | -6 | -20 | -8 |
| Free Cash Flow | -5,889 | -4,616 | -1,862 | -3,574 | -1,086 |